Adaptation of ovine fetal pancreatic insulin secretion to chronic hypoglycaemia and euglycaemic correction

Sean W Limesand, William W. Hay

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Fetal pancreatic adaptations to relative hypoglycaemia, a characteristic of intra-uterine growth restriction, may limit pancreatic β-cell capacity to produce and/or secrete insulin. The objective of this study was to measure β-cell responsiveness in hypoglycaemic (H) fetal sheep and ascertain whether a 5 day euglycaemic recovery period would restore insulin secretion capacity. Glucose-stimulated insulin secretion (GSIS) was measured in euglycaemic (E) control fetuses, fetuses made hypoglycaemic for 14 days, and in a subset of 14-day hypoglycaemic fetuses returned to euglycaemia for 5 days (R fetuses). Hypoglycaemia significantly decreased plasma insulin concentrations in H (0.13 ± 0.01 ng ml-1) and R fetuses (0.11 ± 0.01 ng ml-1); insulin concentrations returned to euglycaemic control values (0.30 ± 0.01 ng ml-1) in R fetuses (0.29 ± 0.04 ng ml-1) during their euglycaemic recovery period. Mean steady-state plasma insulin concentration during the GSIS study was reduced in H fetuses (0.40 ± 0.07 vs. 0.92 ± 0.10 ng ml-1 in E), but increased (P < 0.05) in R fetuses (0.73 ± 0.10 ng ml-1) to concentrations not different from those in the E group. Nonlinear modelling of GSIS showed that response time was greater (P < 0.01) in both H (15.6 ± 2.8 min) and R (15.4 ± 1.5 min) than in E fetuses (6.3 ± 1.1 min). In addition, insulin secretion responsiveness to arginine was reduced by hypoglycaemia (0.98 ± 0.11 ng ml-1 in H vs. 1.82 ± 0.17 ng ml-1 in E, P < 0.05) and did not recover (1.21 ± 0.15 ng ml-1 in R, P < 0.05 vs. E). Thus, a 5 day euglycaemic recovery period from chronic hypoglycaemia reestablished GSIS to normal levels, but there was a persistent reduction of β-cell responsiveness to glucose and arginine. We conclude that programming of pancreatic insulin secretion responsiveness can occur in response to fetal glucose deprivation, indicating a possible mechanism for establishing, in fetal life, a predisposition to type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)95-105
Number of pages11
JournalJournal of Physiology
Volume547
Issue number1
DOIs
StatePublished - Feb 15 2003
Externally publishedYes

Fingerprint

Hypoglycemia
Sheep
Insulin
Fetus
Glucose
Hypoglycemic Agents
Arginine
Type 2 Diabetes Mellitus
Reaction Time

ASJC Scopus subject areas

  • Physiology

Cite this

Adaptation of ovine fetal pancreatic insulin secretion to chronic hypoglycaemia and euglycaemic correction. / Limesand, Sean W; Hay, William W.

In: Journal of Physiology, Vol. 547, No. 1, 15.02.2003, p. 95-105.

Research output: Contribution to journalArticle

@article{01eba42acb494d25802d2f6c347b051e,
title = "Adaptation of ovine fetal pancreatic insulin secretion to chronic hypoglycaemia and euglycaemic correction",
abstract = "Fetal pancreatic adaptations to relative hypoglycaemia, a characteristic of intra-uterine growth restriction, may limit pancreatic β-cell capacity to produce and/or secrete insulin. The objective of this study was to measure β-cell responsiveness in hypoglycaemic (H) fetal sheep and ascertain whether a 5 day euglycaemic recovery period would restore insulin secretion capacity. Glucose-stimulated insulin secretion (GSIS) was measured in euglycaemic (E) control fetuses, fetuses made hypoglycaemic for 14 days, and in a subset of 14-day hypoglycaemic fetuses returned to euglycaemia for 5 days (R fetuses). Hypoglycaemia significantly decreased plasma insulin concentrations in H (0.13 ± 0.01 ng ml-1) and R fetuses (0.11 ± 0.01 ng ml-1); insulin concentrations returned to euglycaemic control values (0.30 ± 0.01 ng ml-1) in R fetuses (0.29 ± 0.04 ng ml-1) during their euglycaemic recovery period. Mean steady-state plasma insulin concentration during the GSIS study was reduced in H fetuses (0.40 ± 0.07 vs. 0.92 ± 0.10 ng ml-1 in E), but increased (P < 0.05) in R fetuses (0.73 ± 0.10 ng ml-1) to concentrations not different from those in the E group. Nonlinear modelling of GSIS showed that response time was greater (P < 0.01) in both H (15.6 ± 2.8 min) and R (15.4 ± 1.5 min) than in E fetuses (6.3 ± 1.1 min). In addition, insulin secretion responsiveness to arginine was reduced by hypoglycaemia (0.98 ± 0.11 ng ml-1 in H vs. 1.82 ± 0.17 ng ml-1 in E, P < 0.05) and did not recover (1.21 ± 0.15 ng ml-1 in R, P < 0.05 vs. E). Thus, a 5 day euglycaemic recovery period from chronic hypoglycaemia reestablished GSIS to normal levels, but there was a persistent reduction of β-cell responsiveness to glucose and arginine. We conclude that programming of pancreatic insulin secretion responsiveness can occur in response to fetal glucose deprivation, indicating a possible mechanism for establishing, in fetal life, a predisposition to type 2 diabetes.",
author = "Limesand, {Sean W} and Hay, {William W.}",
year = "2003",
month = "2",
day = "15",
doi = "10.1113/jphysiol.2002.026831",
language = "English (US)",
volume = "547",
pages = "95--105",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Adaptation of ovine fetal pancreatic insulin secretion to chronic hypoglycaemia and euglycaemic correction

AU - Limesand, Sean W

AU - Hay, William W.

PY - 2003/2/15

Y1 - 2003/2/15

N2 - Fetal pancreatic adaptations to relative hypoglycaemia, a characteristic of intra-uterine growth restriction, may limit pancreatic β-cell capacity to produce and/or secrete insulin. The objective of this study was to measure β-cell responsiveness in hypoglycaemic (H) fetal sheep and ascertain whether a 5 day euglycaemic recovery period would restore insulin secretion capacity. Glucose-stimulated insulin secretion (GSIS) was measured in euglycaemic (E) control fetuses, fetuses made hypoglycaemic for 14 days, and in a subset of 14-day hypoglycaemic fetuses returned to euglycaemia for 5 days (R fetuses). Hypoglycaemia significantly decreased plasma insulin concentrations in H (0.13 ± 0.01 ng ml-1) and R fetuses (0.11 ± 0.01 ng ml-1); insulin concentrations returned to euglycaemic control values (0.30 ± 0.01 ng ml-1) in R fetuses (0.29 ± 0.04 ng ml-1) during their euglycaemic recovery period. Mean steady-state plasma insulin concentration during the GSIS study was reduced in H fetuses (0.40 ± 0.07 vs. 0.92 ± 0.10 ng ml-1 in E), but increased (P < 0.05) in R fetuses (0.73 ± 0.10 ng ml-1) to concentrations not different from those in the E group. Nonlinear modelling of GSIS showed that response time was greater (P < 0.01) in both H (15.6 ± 2.8 min) and R (15.4 ± 1.5 min) than in E fetuses (6.3 ± 1.1 min). In addition, insulin secretion responsiveness to arginine was reduced by hypoglycaemia (0.98 ± 0.11 ng ml-1 in H vs. 1.82 ± 0.17 ng ml-1 in E, P < 0.05) and did not recover (1.21 ± 0.15 ng ml-1 in R, P < 0.05 vs. E). Thus, a 5 day euglycaemic recovery period from chronic hypoglycaemia reestablished GSIS to normal levels, but there was a persistent reduction of β-cell responsiveness to glucose and arginine. We conclude that programming of pancreatic insulin secretion responsiveness can occur in response to fetal glucose deprivation, indicating a possible mechanism for establishing, in fetal life, a predisposition to type 2 diabetes.

AB - Fetal pancreatic adaptations to relative hypoglycaemia, a characteristic of intra-uterine growth restriction, may limit pancreatic β-cell capacity to produce and/or secrete insulin. The objective of this study was to measure β-cell responsiveness in hypoglycaemic (H) fetal sheep and ascertain whether a 5 day euglycaemic recovery period would restore insulin secretion capacity. Glucose-stimulated insulin secretion (GSIS) was measured in euglycaemic (E) control fetuses, fetuses made hypoglycaemic for 14 days, and in a subset of 14-day hypoglycaemic fetuses returned to euglycaemia for 5 days (R fetuses). Hypoglycaemia significantly decreased plasma insulin concentrations in H (0.13 ± 0.01 ng ml-1) and R fetuses (0.11 ± 0.01 ng ml-1); insulin concentrations returned to euglycaemic control values (0.30 ± 0.01 ng ml-1) in R fetuses (0.29 ± 0.04 ng ml-1) during their euglycaemic recovery period. Mean steady-state plasma insulin concentration during the GSIS study was reduced in H fetuses (0.40 ± 0.07 vs. 0.92 ± 0.10 ng ml-1 in E), but increased (P < 0.05) in R fetuses (0.73 ± 0.10 ng ml-1) to concentrations not different from those in the E group. Nonlinear modelling of GSIS showed that response time was greater (P < 0.01) in both H (15.6 ± 2.8 min) and R (15.4 ± 1.5 min) than in E fetuses (6.3 ± 1.1 min). In addition, insulin secretion responsiveness to arginine was reduced by hypoglycaemia (0.98 ± 0.11 ng ml-1 in H vs. 1.82 ± 0.17 ng ml-1 in E, P < 0.05) and did not recover (1.21 ± 0.15 ng ml-1 in R, P < 0.05 vs. E). Thus, a 5 day euglycaemic recovery period from chronic hypoglycaemia reestablished GSIS to normal levels, but there was a persistent reduction of β-cell responsiveness to glucose and arginine. We conclude that programming of pancreatic insulin secretion responsiveness can occur in response to fetal glucose deprivation, indicating a possible mechanism for establishing, in fetal life, a predisposition to type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0037440658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037440658&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2002.026831

DO - 10.1113/jphysiol.2002.026831

M3 - Article

C2 - 12562941

AN - SCOPUS:0037440658

VL - 547

SP - 95

EP - 105

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 1

ER -